Antibody Therapeutics
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
40
NCT06181786
Study of NAV-240 in Healthy Volunteers
Phase: Phase 1
Role: Collaborator
Start: Nov 22, 2023
Completion: Sep 4, 2024
Loading map...